↓ Skip to main content

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

Overview of attention for article published in BMC Infectious Diseases, May 2014
Altmetric Badge

Citations

dimensions_citation
63 Dimensions

Readers on

mendeley
85 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study
Published in
BMC Infectious Diseases, May 2014
DOI 10.1186/1471-2334-14-289
Pubmed ID
Authors

Martin E Stryjewski, Arnold Lentnek, William O’Riordan, John Pullman, Paul Anantharajah Tambyah, Jose M Miró, Vance G Fowler Jr, Steven L Barriere, Michael M Kitt, G Ralph Corey

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Argentina 1 1%
Unknown 84 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 11 13%
Researcher 10 12%
Student > Master 9 11%
Student > Doctoral Student 6 7%
Student > Postgraduate 6 7%
Other 16 19%
Unknown 27 32%
Readers by discipline Count As %
Medicine and Dentistry 24 28%
Pharmacology, Toxicology and Pharmaceutical Science 10 12%
Biochemistry, Genetics and Molecular Biology 5 6%
Nursing and Health Professions 5 6%
Unspecified 3 4%
Other 5 6%
Unknown 33 39%